Cargando…

The CB(2) Receptor as a Novel Therapeutic Target for Epilepsy Treatment

Epilepsy is characterized by repeated spontaneous bursts of neuronal hyperactivity and high synchronization in the central nervous system. It seriously affects the quality of life of epileptic patients, and nearly 30% of individuals are refractory to treatment of antiseizure drugs. Therefore, there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Xiaoyu, Zeng, Yang, Wu, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396521/ https://www.ncbi.nlm.nih.gov/pubmed/34445666 http://dx.doi.org/10.3390/ijms22168961

Ejemplares similares

New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
por: Kibret, Berhanu Geresu, et al.
Publicado: (2022)

Targeting the Ghrelin Receptor as a Novel Therapeutic Option for Epilepsy
por: Buckinx, An, et al.
Publicado: (2021)

CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
por: Zhou, Juan, et al.
Publicado: (2016)

Cannabinoid CB(1) and CB(2) Receptor Signaling and Bias
por: Ibsen, Mikkel Søes, et al.
Publicado: (2017)

Epilepsy: Novel therapeutic targets
por: Anovadiya, Ashish P., et al.
Publicado: (2012)

Serotonin receptors in epilepsy: Novel treatment targets?
por: Sourbron, Jo, et al.
Publicado: (2022)

Are CB2 Receptors a New Target for Schizophrenia Treatment?
por: Cortez, Isadora L., et al.
Publicado: (2020)

Novel astrocyte targets: New Avenues for the Therapeutic Treatment of Epilepsy
por: Crunelli, Vincenzo, et al.
Publicado: (2015)

Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
por: Vuic, Barbara, et al.
Publicado: (2022)

Editorial: Therapeutic potential of the cannabinoid CB2 receptor
por: Smoum, Reem, et al.
Publicado: (2022)

CB2 Receptor Involvement in the Treatment of Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021)

Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs
por: Murphy, Thomas, et al.
Publicado: (2020)

Microglial Cannabinoid CB(2) Receptors in Pain Modulation
por: Xu, Kangtai, et al.
Publicado: (2023)

Cannabigerol Action at Cannabinoid CB(1) and CB(2) Receptors and at CB(1)–CB(2) Heteroreceptor Complexes
por: Navarro, Gemma, et al.
Publicado: (2018)

Structural and functional insights into the G protein-coupled receptors: CB1 and CB2
por: Brust, Christina A., et al.
Publicado: (2023)

Functional characterization of the novel cannabinoid receptor GPR55 and its modulation by CB(1 )and CB(2 )receptors
por: Balenga, Nariman, et al.
Publicado: (2008)

Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model
por: Greco, Rosaria, et al.
Publicado: (2014)

Network science for the identification of novel therapeutic targets in epilepsy
por: Scott, Rod C.
Publicado: (2016)

Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB(1)/CB(2) Receptor Interaction
por: Asproni, Battistina, et al.
Publicado: (2021)

The Antimicrobial Properties of Cannabis and Cannabis-Derived Compounds and Relevance to CB2-Targeted Neurodegenerative Therapeutics
por: Hong, HeeJue, et al.
Publicado: (2022)

Preclinical evidence of ghrelin as a therapeutic target in epilepsy
por: Ge, Tongtong, et al.
Publicado: (2017)

Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors
por: El-Atawneh, Shayma, et al.
Publicado: (2022)

Brain CB(2) Receptors: Implications for Neuropsychiatric Disorders
por: Roche, Michelle, et al.
Publicado: (2010)

CB2 Receptor in Microglia: The Guardian of Self-Control
por: Komorowska-Müller, Joanna Agnieszka, et al.
Publicado: (2020)

An Update on Non-CB(1), Non-CB(2) Cannabinoid Related G-Protein-Coupled Receptors
por: Morales, Paula, et al.
Publicado: (2017)

Overview of Nrf2 as Therapeutic Target in Epilepsy
por: Carmona-Aparicio, Liliana, et al.
Publicado: (2015)

Redistribution of CB1 Cannabinoid Receptors in the Acute and Chronic Phases of Pilocarpine-Induced Epilepsy
por: Karlócai, Mária R., et al.
Publicado: (2011)

The CB(2) receptor and its role as a regulator of inflammation
por: Turcotte, Caroline, et al.
Publicado: (2016)

Intestinal Microbiota as an Alternative Therapeutic Target for Epilepsy
por: Wu, Jiaying, et al.
Publicado: (2016)

Central CB(2) receptors in inflammation-driven neurodegeneration: dysregulation and therapeutic potential
por: Concannon, Ruth M., et al.
Publicado: (2016)

The Binding Mode to Orthosteric Sites and/or Exosites Underlies the Therapeutic Potential of Drugs Targeting Cannabinoid CB(2) Receptors
por: Franco, Rafael, et al.
Publicado: (2022)

CB(2) Cannabinoid Receptor As Potential Target against Alzheimer's Disease
por: Aso, Ester, et al.
Publicado: (2016)

Recent treatment advances and novel therapeutic approaches in epilepsy
por: Serrano, Enrique, et al.
Publicado: (2015)

Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
por: Polini, Beatrice, et al.
Publicado: (2020)

Transcription factors are potential therapeutic targets in epilepsy
por: Sun, Qihan, et al.
Publicado: (2022)

Drug-Resistant Temporal Lobe Epilepsy Alters the Expression and Functional Coupling to Gαi/o Proteins of CB1 and CB2 Receptors in the Microvasculature of the Human Brain
por: Nuñez-Lumbreras, María de los Ángeles, et al.
Publicado: (2021)

Cannabinoid Receptors CB1 and CB2 Modulate the Electroretinographic Waves in Vervet Monkeys
por: Bouskila, Joseph, et al.
Publicado: (2016)

Coupling of CB-2 and CB-1
por: Ansaldo
Publicado: (2003)

Targeting ferroptosis as novel therapeutic approaches for epilepsy
por: Jin, Yuzi, et al.
Publicado: (2023)

CB1 Cannabinoid Receptor Signaling and Biased Signaling
por: Leo, Luciana M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dh2iv3n2dd94qgslchg3iim54k